These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Preliminary results of a pilot study using WR-2721 before fractionated irradiation of the head and neck to reduce salivary gland dysfunction. McDonald S; Meyerowitz C; Smudzin T; Rubin P Int J Radiat Oncol Biol Phys; 1994 Jul; 29(4):747-54. PubMed ID: 8040020 [TBL] [Abstract][Full Text] [Related]
3. Radiation apoptosis of serous acinar cells of salivary and lacrimal glands. Stephens LC; Schultheiss TE; Price RE; Ang KK; Peters LJ Cancer; 1991 Mar; 67(6):1539-43. PubMed ID: 2001542 [TBL] [Abstract][Full Text] [Related]
4. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy. Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009 [TBL] [Abstract][Full Text] [Related]
5. Oral pH changes due to salivary gland irradiation during radiation therapy of oral and head and neck cancer. Viswanath L; Bhanumathi G; Reddy BK; Prabhakaran PS Indian J Dent Res; 2004; 15(4):137-8. PubMed ID: 16035642 [No Abstract] [Full Text] [Related]
6. 11C-methionine PET, a novel method for measuring regional salivary gland function after radiotherapy of head and neck cancer. Buus S; Grau C; Munk OL; Bender D; Jensen K; Keiding S Radiother Oncol; 2004 Dec; 73(3):289-96. PubMed ID: 15588873 [TBL] [Abstract][Full Text] [Related]
8. Salivary gland sparing in the treatment of head and neck cancer. Scrimger R Expert Rev Anticancer Ther; 2011 Sep; 11(9):1437-48. PubMed ID: 21929317 [TBL] [Abstract][Full Text] [Related]
9. Comprehensive irradiation of head and neck cancer using conformal multisegmental fields: assessment of target coverage and noninvolved tissue sparing. Eisbruch A; Marsh LH; Martel MK; Ship JA; Ten Haken R; Pu AT; Fraass BA; Lichter AS Int J Radiat Oncol Biol Phys; 1998 Jun; 41(3):559-68. PubMed ID: 9635702 [TBL] [Abstract][Full Text] [Related]
11. [Quantitative and qualitative investigations of salivary gland function in dependence on irradiation dose and volume for reduction of xerostomia in patients with head-and-neck cancer]. Kuhnt T; Jirsak N; Müller AC; Pelz T; Gernhardt C; Schaller HG; Janich M; Gerlach R; Dunst J Strahlenther Onkol; 2005 Aug; 181(8):520-8. PubMed ID: 16044220 [TBL] [Abstract][Full Text] [Related]
12. Salivary flow rates in patients with head and neck cancer 0.5 to 25 years after radiotherapy. Liu RP; Fleming TJ; Toth BB; Keene HJ Oral Surg Oral Med Oral Pathol; 1990 Dec; 70(6):724-9. PubMed ID: 2263329 [TBL] [Abstract][Full Text] [Related]
13. Maintained salivary function after brachytherapy in patients with head and neck carcinomas--evaluation using quantitative salivary gland scintigraphy. Murata Y; Zhang L; Ishida R; Aung W; Taura S; Hossain M; Yoshimura R; Hoshina M; Akaike H; Sugaya T; Shibuya H Acta Oncol; 2002; 41(7-8):684-8. PubMed ID: 14651214 [TBL] [Abstract][Full Text] [Related]
14. Accuracy requirements for head and neck intensity-modulated radiation therapy based on observed dose response of the major salivary glands. Kapanen M; Collan J; Saarilahti K; Heikkonen J; Kairemo K; Tenhunen M Radiother Oncol; 2009 Oct; 93(1):109-14. PubMed ID: 19435641 [TBL] [Abstract][Full Text] [Related]
15. Salivary gland sparing and improved target irradiation by conformal and intensity modulated irradiation of head and neck cancer. Eisbruch A; Ship JA; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Hogikyan ND; Anzai Y; Marsh LH; Ten Haken RK; Wolf GT World J Surg; 2003 Jul; 27(7):832-7. PubMed ID: 14509515 [TBL] [Abstract][Full Text] [Related]
16. Use of diffusion-weighted magnetic resonance imaging (DW-MRI) to investigate the effect of chemoradiotherapy on the salivary glands. Doornaert P; Dahele M; Ljumanovic R; de Bree R; Slotman BJ; Castelijns JA Acta Oncol; 2015 Jul; 54(7):1068-71. PubMed ID: 25519706 [No Abstract] [Full Text] [Related]
17. Delineation guidelines for organs at risk involved in radiation-induced salivary dysfunction and xerostomia. van de Water TA; Bijl HP; Westerlaan HE; Langendijk JA Radiother Oncol; 2009 Dec; 93(3):545-52. PubMed ID: 19853316 [TBL] [Abstract][Full Text] [Related]
18. Radiation-Induced Loss of Salivary Gland Function Is Driven by Cellular Senescence and Prevented by IL6 Modulation. Marmary Y; Adar R; Gaska S; Wygoda A; Maly A; Cohen J; Eliashar R; Mizrachi L; Orfaig-Geva C; Baum BJ; Rose-John S; Galun E; Axelrod JH Cancer Res; 2016 Mar; 76(5):1170-80. PubMed ID: 26759233 [TBL] [Abstract][Full Text] [Related]
20. Xerostomia prevention after head and neck cancer treatment. Seikaly H Arch Otolaryngol Head Neck Surg; 2003 Feb; 129(2):250-1. PubMed ID: 12578460 [No Abstract] [Full Text] [Related] [Next] [New Search]